Home > Insider Trading > Filing (0001140361-14-004492)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093649	Idenix Pharmaceuticals Inc	IDIX	Pharmaceutical Preparations (2834)	450478605

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
899869	A Seth Klarman	10 St. James Ave. Suite 1700 Boston MA 02116	No	No	Yes	No
1061088	Sak Corp	10 St James Avenue Ste 1700 Boston MA 02116	No	No	Yes	No
1061768	Baupost Group Llc/Ma	10 St James Ave Suite 1700 Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-01-31	16,420,241	$6.50	53,331,109	No	4	P	Indirect	See footnote.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote.

Footnotes

This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), SAK Corporation and Seth A. Klarman. Baupost is a registered investment adviser and acts as an investment adviser and general partner to certain private investment limited partnerships. SAK Corporation is the manager of Baupost. Mr. Klarman, as the sole director and sole officer of SAK Corporation and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934 of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost include securities purchased on behalf of various private investment limited partnerships. The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest therein.